Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2559-2564

  Yamaue, Hiroki ^a   Tanimura, Hiroshi ^a   Kono, Nobuji ^b   Aoki, Yozo ^b   Tabuse, Katsuyoshi ^b   Uchiyama, Kazuhisa ^a   Takifuji, Katsunari ^a   Iwahashi, Makoto ^a   Tani, Masaji ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Chemosensitivity test; Colorectal cancer; Doxifluridine; Thymidine phosphorylase

Indexed keywords

CAPECITABINE; DOXIFLURIDINE; FLUOROURACIL; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOSENSITIVITY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; TIME SERIES ANALYSIS;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; THYMIDINE PHOSPHORYLASE;

EID: 0042807562     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Yamada Y, Kubota T and Kawamura E et al: Human tumor cell clonogenic assay with reference to the clinical effect of chemotherapy. Surg Res Comm 4: 41-51, 1988.
2. Saikawa Y, Kubota T and Furukawa T et al: Single-cell suspension assay with an MTT endpoint is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer. Jpn J Cancer Res 85: 762-765, 1994.
3. Kubota T, Sasano N and Abe O et al: The potential of the histoculture drug response assay to contribute to cancer patient survival. Clin Cancer Res 1: 1537-1543, 1995.
4. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
5. Jaspers GEL, Peters R and Van Zantwijk CH et al: In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemia cells from bone marrow and peripheral blood. Br J Cancer 64: 469-474, 1991.
6. Campling BG, Baker HM and Cole SP et al: Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 63: 75-83, 1991.
7. Yamaue H, Tanimura H and Tsunoda T et al: Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay. Eur J Cancer 27: 1258-1263, 1991.
8. Yamaue H, Tanimura H and Noguchi K et al: Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer 66: 794-799, 1992.
9. Yamaue H, Tanimura H and Nakamori M et al: Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay. Dis Colon Rectum 39: 416-422. 1996.
10. Cutsem EV, Findlay M and Osterwalder B et al: Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol 18: 1337-1345, 2000.
11. Cutsem EV, Twelves C and Cassidy J et al: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19(21): 4097-4106, 2001.
12. Niitani H, Kimura K and Saito T et al: Phase II study of 5'deoxy-5-fluorouridine (5'-DFUR) on patients with malignant cancer: multi-institutional cooperative study. Jpn J Cancer Chemother 12: 2044-2051, 1985.
13. Kono A, Hara Y, Sugata S, Karube Y, Matsushima Y and Ishitsuka H: Activation of 5'-deoxy5-fluorouridine by thymidine phosphorylase in human tumors. Chem Pharm Bull 31: 175-178, 1983.
14. Eda H, Fujimoto K and Watanabe S et al: Cytokines induce thymidine phophorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
15. Haraguchi M, Furukawa T, Sumizawa T and Akiyama S: Sensitivity of human KB cells expression platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 53: 5680-5682, 1993.
16. Koizumi W, Saigenji K, Nakamaru N, Okayasu I and Kurihara M: Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor. Oncology 56: 215-222, 1999.
17. Yamamoto Y, Toi M and Tominaga T: Prediction of the effect of 5'-deoxy-5-fluorouridine by the status of angiogenic enzyme thymidine phosphorylase expression in recurrent breast cancer patients. Oncol Rep 3: 863-865, 1996.
18. Nishida M, Hino A and Mori K et al: Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharma Bull 19: 1407-1411, 1996.
19. Sakamoto J, Hamada C and Kodaira S et al: Adjuvant therapy with oral fluorouridines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol 29: 78-86, 1999.
20. Furukawa T, Sumizawa T, Haraguchi M and Akiyama S: Angiogenic factor. Nature 356: 668, 1992.
21. Miyadera K, Sumizawa T and Haraguchi M et al: Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 55: 1687-1690, 1995.
22. Takebayashi Y, Akiyama S and Akiba S et al: Clinicopathologic and prognostic significance of an angiogenic factor thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1116-1117, 1996.
23. Matsumura M, Chiba C and Lu C et al: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer. Cancer Lett 128: 55-63, 1998.
24. Saito S, Tsuno N and Nagawa H et al: Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma. Cancer 88: 42-49, 2000.
25. Salonga D, Danenberg DK and Johnson M et al: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidilate synthase and thymidine phosphorylase. Clin Cancer Res 6: 1322-1327, 2000.
26. Ishikawa T, Sekiguchi F, Fukase Y, Sawada N and Ishitsuka H: Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58: 685-690, 1998.